Israel Study Finds 4th Booster Shot Ineffective — Moderna and Biotech Stocks Are Cratering

An Israeli study found that the 4th COVID booster shot is ineffective in preventing the disease.
This is horrible news for the Medical Industrial Complex.

Via James Cintolo.

A study out of Sheba Medical Center in Israel has proven that a 4th dose of either Pfizer or Moderna is ineffective against Omicron. Preliminary data was released on Monday 1/17/22 showing high antibody titers but low protection. Here’s an examination of the data, and 3 lessons we can learn from this.

To start, 274 healthcare workers at Sheba Medical Center received a 4th dose. Specifically, 154 received Pfizer, and 120 received Moderna. They were compared with a control group of nearly 6,000 healthcare workers that didn’t receive a booster. Prof. Gili Regev-Yochay, lead researcher commented, “We see an increase in antibodies, higher than after the third dose,” he stated. “However, we see many infected with Omicron who received the fourth dose”. T elaborate, around the same number of individuals that received 4 doses experienced as many breakthrough infections as those who received 3. That said, there are a few lessons to learn from this.

TRENDING: New West Charter School LA Caught Abusing Young Unvaccinated Girls – Denied Chairs, Forced to Sit Outside on Pavement, Not Allowed to Use Restrooms

This may explain the crash in vaccine stocks Moderna and BioTech.

Alex Berenson reported:

The hedge funds have finally realized there will be no fourth shot. And that mRNA technology, erm, still has a few issues to work out. (1 billion people aren’t gonna love hearing that, but too late now. Mistakes were made, stuff happens, amirite?)

Moderna and BioNTech are down 8-10% today, 60% since August. Oh, how I wish I could have shorted them.



Jim Hoft